Article info

Download PDFPDF

Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study

Authors

  1. Correspondence to Elise van Mulligen, Rheumatology, Erasmus MC, Rotterdam 3015, Netherlands; elise.vanmulligen{at}erasmusmc.nl
View Full Text

Citation

van Mulligen E, de Jong PHP, Kuijper TM, et al
Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study

Publication history

  • Received December 21, 2018
  • Revised March 14, 2019
  • Accepted March 16, 2019
  • First published April 6, 2019.
Online issue publication 
May 14, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.